Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells

Journal of Controlled Release

Volumn 95, Issue 2, 2004, Pages 321-331

  Yang, Lijuan ^a   Li, Jiang ^a   Zhou, Wen ^a   Yuan, Xing ^a   Li, Song ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antisense; Folate; Lipid vector; Oligodeoxynucleotides; Targeting

Indexed keywords

DEGRADATION; LIPIDS; PATIENT TREATMENT; TUMORS;

ANTISENSE;

CELLS;

ANTISENSE OLIGODEOXYNUCLEOTIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLATE RECEPTOR; LIPID; NUCLEOTIDE; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ARTICLE; CANCER THERAPY; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME DEGRADATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LIPID VESICLE; PRIORITY JOURNAL; PROTECTION; STATISTICAL SIGNIFICANCE; TUMOR CELL;

EID: 1242271282     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.11.021     Document Type: Article

References (29)

1. Agrawal S., Kandimalla E.R. Antisense and/or immunostimulatory oligonucleotide therapeutics. Curr. Cancer Drug Targets. 1:2001;197-209.
2. Dias N., Stein C.A. Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides. Eur. J. Pharm. Biopharm. 54:2002;263-269.
3. Bennett C.F., Chiang M.Y., Chan H., Shoemaker J.E., Mirabelli C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41:1992;1023-1033.
4. Cumin F., Asselbergs F., Lartigot M., Felder E. Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cells. Eur. J. Biochem. 212:1993;347-354.
5. Wang S., Lee R.J., Cauchon G., Gorenstein D.G., Low P.S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
6. Litzinger D.C., Brown J.M., Wala I., Kaufman S.A., Van G.Y., Farrell C.L., Collins D. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta. 1281:1996;139-149.
7. Li S., Huang L. Lipidic supramolecular assemblies for gene transfer. J. Liposome Res. 6:1996;589-608.
8. Maruyama K. In vivo targeting by liposomes. Biol. Pharm. Bull. 23:2000;791-799.
9. Semple S.C., Klimuk S.K., Harasym T.O., Dos Santos N., Ansell S.M., Wong K.F., Maurer N., Stark H., Cullis P.R., Hope M.J., Scherrer P. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta. 1510:2001;152-166.
10. Zhou W., Yuan X., Wilson A., Yang L., Mokotoff M., Pitt B., Li S. Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjug. Chem. 13:2002;1220-1225.
11. Ciardiello F., Caputo R., Troiani T., Borriello G., Kandimalla E.R., Agrawal S., Mendelsohn J., Bianco A.R., Tortora G. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines. Int. J. Cancer. 93:2001;172-178.
12. Grandis J.R., Chakraborty A., Zeng Q., Melhem M.F., Tweardy D.J. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. J. Cell. Biochem. 69:1998;55-62.
13. Ashida M., Bito T., Budiyanto A., Ichihashi M., Ueda M. Involvement of EGF receptor activation in the induction of cyclooxygenase-2 in HaCaT keratinocytes after UVB. Exp. Dermatol. 12:2003;445-452.
14. Li S., Khokhar A.R., Perez-Soler R., Huang L. Improved antitumor activity of cis-Bis-neodecanoato-trans-R, R-1,2-diaminocyclo-hexaneplatinum (II) entrapped in long-circulating liposomes. Oncol. Res. 7:1995;611-617.
15. Prewett M.C., Hooper A.T., Bassi R., Ellis L.M., Waksal H.W., Hicklin D.J. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. Clin. Cancer Res. 8:2002;994-1003.
16. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta. 1233:1995;134-144.
17. Mathias C.J., Wang S., Lee R.J., Waters D.J., Low P.S., Green M.A. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J. Nucl. Med. 37:1996;1003-1008.
18. Guo W., Hinkle G.H., Lee R.J. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40:1999;1563-1569.
19. Leamon C.P., Cooper S.R., Hardee G.E. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo. Bioconjug. Chem. 14:2003;738-747.
20. Xu L., Pirollo K.F., Chang E.H. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J. Control. Release. 74:2001;115-128.
21. Reddy J.A., Abburi C., Hofland H., Howard S.J., Vlahov I., Wils P., Leamon C.P. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 9:2002;1542-1550.
22. Gosselin M.A., Guo W., Lee R.J. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjug. Chem. 13:2002;1044-1053.
23. Budker V., Gurevich V., Hagstrom J.E., Bortzov F., Wolff J.A. pH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nat. Biotechnol. 14:1996;760-764.
24. Lee R.J., Huang L. Lipidic vector systems for gene transfer. Crit. Rev. Ther. Drug Carrier Syst. 14:1997;173-206.
25. Zelphati O., Szoka F.C. Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA. 93:1996;11493-11498.
26. Xu Y.H., Richert N., Ito S., Merlino G.T., Pastan I. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc. Natl. Acad. Sci. USA. 81:1984;7308-7312.
27. Carpenter G., Cohen S. Epidermal growth factor. J. Biol. Chem. 265:1990;7709-7712.
28. Hunter T. Cooperation between oncogenes. Cell. 64:1991;249-270.
29. Arteaga C.L. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist. 7:2002;31-39.